Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fulcher

Showing results (41-50 of 169) with videos related to

Pageof 17
Sort By:
The Journal of Allergy and Clinical Immunology|April 25, 2006
TACI mutation with invasive polyclonal CD8+ T-cell lymphoproliferation in a patient with common variable immunodeficiencyLucinda J Berglund, Graham J Jones, Rajmohan Murali, et al.
Blood|October 1, 1989
An arginine to cysteine amino acid substitution at a critical thrombin cleavage site in a dysfunctional factor VIII moleculeM Shima, J Ware, A Yoshioka, et al.
Age and Ageing|June 22, 2006
Utilisation of diagnostic computerised tomography imaging and immediate clinical outcomes in older people with stroke before and after introduction of the National Service Framework for older people. A comparative study of hospital-based stroke registry data (1997-2003): Norfolk experiencePhyo K Myint, Sarah L Vowler, Oliver Redmayne, et al.
Gerontology|April 15, 2008
Cognition, continence and transfer status at the time of discharge from an acute hospital setting and their associations with an unfavourable discharge outcome after strokePhyo K Myint, Sarah L Vowler, Oliver Redmayne, et al.
Thrombosis and Haemostasis|June 28, 1990
A synthetic factor VIII peptide of eight amino acid residues (1677-1684) contains the binding region of an anti-factor VIII antibody which inhibits the binding of factor VIII to von Willebrand factorP A Foster, C A Fulcher, R A Houghten, et al.
Blood|February 1, 1984
Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor VC A Fulcher, J E Gardiner, J H Griffin, et al.
The Journal of Biological Chemistry|April 15, 1988
An immunogenic region within residues Val1670-Glu1684 of the factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factorP A Foster, C A Fulcher, R A Houghten, et al.
Digital Health|May 20, 2020
#selfharn on Instagram: understanding online communities surrounding non-suicidal self-injury through conversations and common properties among authorsJory A Fulcher, Sarah Dunbar, Elizabeth Orlando, et al.
The Journal of Clinical Investigation|July 1, 1985
Human factor VIII procoagulant protein. Monoclonal antibodies define precursor-product relationships and functional epitopesC A Fulcher, J R Roberts, L Z Holland, et al.
Internal Medicine Journal|December 24, 2014
Treatment outcomes in a cohort of patients with mucosal-predominant pemphigus vulgarisS Ojaimi, K O'Connor, M W Lin, et al.
Pageof 17

Showing results (41-50 of 169) with videos related to

Sort By:
Pageof 17
The Journal of Allergy and Clinical Immunology|April 25, 2006
TACI mutation with invasive polyclonal CD8+ T-cell lymphoproliferation in a patient with common variable immunodeficiencyLucinda J Berglund, Graham J Jones, Rajmohan Murali, et al.
Blood|October 1, 1989
An arginine to cysteine amino acid substitution at a critical thrombin cleavage site in a dysfunctional factor VIII moleculeM Shima, J Ware, A Yoshioka, et al.
Age and Ageing|June 22, 2006
Utilisation of diagnostic computerised tomography imaging and immediate clinical outcomes in older people with stroke before and after introduction of the National Service Framework for older people. A comparative study of hospital-based stroke registry data (1997-2003): Norfolk experiencePhyo K Myint, Sarah L Vowler, Oliver Redmayne, et al.
Gerontology|April 15, 2008
Cognition, continence and transfer status at the time of discharge from an acute hospital setting and their associations with an unfavourable discharge outcome after strokePhyo K Myint, Sarah L Vowler, Oliver Redmayne, et al.
Thrombosis and Haemostasis|June 28, 1990
A synthetic factor VIII peptide of eight amino acid residues (1677-1684) contains the binding region of an anti-factor VIII antibody which inhibits the binding of factor VIII to von Willebrand factorP A Foster, C A Fulcher, R A Houghten, et al.
Blood|February 1, 1984
Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor VC A Fulcher, J E Gardiner, J H Griffin, et al.
The Journal of Biological Chemistry|April 15, 1988
An immunogenic region within residues Val1670-Glu1684 of the factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factorP A Foster, C A Fulcher, R A Houghten, et al.
Digital Health|May 20, 2020
#selfharn on Instagram: understanding online communities surrounding non-suicidal self-injury through conversations and common properties among authorsJory A Fulcher, Sarah Dunbar, Elizabeth Orlando, et al.
The Journal of Clinical Investigation|July 1, 1985
Human factor VIII procoagulant protein. Monoclonal antibodies define precursor-product relationships and functional epitopesC A Fulcher, J R Roberts, L Z Holland, et al.
Internal Medicine Journal|December 24, 2014
Treatment outcomes in a cohort of patients with mucosal-predominant pemphigus vulgarisS Ojaimi, K O'Connor, M W Lin, et al.
Pageof 17